data_2kro_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kro _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.711 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 3.4 mmpt? . . . . . 0 C--O 1.233 0.191 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.55 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.629 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HB3' HD21 ' A' ' 23' ' ' LEU . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.633 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' HD23 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.579 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' CG1' ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.681 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 36' ' ' LYS . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD23 ' A' ' 33' ' ' LEU . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' CG1' HD23 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HG3' HD12 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.604 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.436 HD23 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.431 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' HG3' HD23 ' A' ' 33' ' ' LEU . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' HD21 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' HG13 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG13 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.547 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.496 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.618 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.537 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.509 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.558 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.671 0.272 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.432 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.538 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.471 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.552 ' HA ' HG21 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 23' ' ' LEU . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.428 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.511 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.53 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.523 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.617 0.367 . . . . 0.0 111.387 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.2 ttp -115.35 48.88 1.12 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.86 179.87 39.12 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 119.915 -1.135 . . . . 0.0 113.418 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.14 -24.31 14.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.711 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 3.4 mmpt? -126.7 129.91 49.34 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.439 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.629 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.55 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.629 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HB3' HD21 ' A' ' 23' ' ' LEU . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -81.07 134.42 35.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.98 -41.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.822 -179.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.9 -97.75 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.99 -0.528 . . . . 0.0 111.816 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 tpp -110.92 28.42 8.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.408 1.004 . . . . 0.0 111.579 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.89 166.72 36.03 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.049 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' GLU . . . -102.64 -115.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -44.06 103.54 0.03 OUTLIER 'General case' 0 C--N 1.347 0.482 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.633 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' HD23 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.579 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.432 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 -72.69 134.96 45.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.27 -48.67 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.375 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.896 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -84.92 145.42 27.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.798 0.333 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 28.2 ttt 173.69 117.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.445 173.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -15.7 82.53 0.0 OUTLIER Glycine 0 C--N 1.345 1.077 0 N-CA-C 115.269 0.868 . . . . 0.0 115.269 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.13 6.96 12.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.025 0.912 . . . . 0.0 112.421 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 27.8 mtmm 74.62 49.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' CG1' ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.681 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 36' ' ' LYS . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD23 ' A' ' 33' ' ' LEU . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' CG1' HD23 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.61 132.58 35.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.12 -43.7 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.99 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.881 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.554 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . . . -87.2 146.8 25.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.614 0.245 . . . . 0.0 110.901 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 5' ' ' ALA . 6.3 ttt -171.01 120.23 0.52 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.83 79.47 0.0 OUTLIER Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' MET . . . -122.99 8.34 9.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.08 0.94 . . . . 0.0 112.747 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt 74.07 72.22 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HG3' HD12 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.604 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.436 HD23 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.431 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 2' ' ' ALA . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.91 134.78 34.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -70.15 -59.03 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.373 -178.245 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.62 95.87 2.77 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -96.42 121.13 37.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 112.348 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -28.6 127.95 0.08 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.44 -1.254 . . . . 0.0 115.279 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.17 16.59 14.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.684 0.742 . . . . 0.0 111.484 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? 66.7 65.92 0.45 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' HD21 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.453 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' HG13 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG13 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.547 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -87.46 133.73 33.71 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -54.89 -38.39 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.504 0.193 . . . . 0.0 111.251 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.757 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.539 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . . . -105.69 149.1 26.68 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.744 0.307 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -177.7 118.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 173.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -16.77 79.31 0.0 OUTLIER Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -121.84 7.13 9.88 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.249 1.025 . . . . 0.0 112.603 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 5.3 mtmm 75.42 50.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.618 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.537 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 2' ' ' ALA . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.509 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.91 130.03 36.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.2 -39.85 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.859 -179.376 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.04 -86.35 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tpt -117.1 32.2 6.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.044 0.838 . . . . 0.0 112.844 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.08 164.8 32.35 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.173 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.22 -28.36 12.33 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -125.66 105.34 8.93 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.613 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.558 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 -79.72 141.35 36.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.37 -48.45 85.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.983 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.23 146.64 53.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.71 0.291 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' GLY . 3.2 mtt 170.48 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.42 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -4.25 68.58 0.0 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -111.41 0.52 16.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.533 1.167 . . . . 0.0 111.685 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 25.6 mtmm 78.62 49.54 0.04 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.187 0.304 . . . . 0.0 110.612 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.432 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.509 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.538 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -78.12 141.46 38.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.9 mm -63.89 -49.12 83.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.75 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.706 -0.158 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.73 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.721 0.408 . . . . 0.0 111.395 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.1 mtp -114.78 109.73 18.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.198 0.454 . . . . 0.0 111.599 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.61 -179.66 25.53 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.832 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.97 -32.94 11.04 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.19 124.99 43.67 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.249 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.471 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.552 ' HA ' HG21 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 23' ' ' LEU . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.428 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.53 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -83.07 133.84 35.05 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.56 -43.47 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.629 0.252 . . . . 0.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.763 -179.316 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 36' ' ' LYS . . . -72.59 155.56 39.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.07 0.462 . . . . 0.0 111.825 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 15.4 tpt 172.36 116.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.011 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.65 86.68 0.0 OUTLIER Glycine 0 C--N 1.347 1.18 0 CA-C-O 119.103 -0.832 . . . . 0.0 114.773 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.23 12.39 13.46 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.798 1.299 . . . . 0.0 112.828 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 35.1 mtmm 70.11 59.92 0.25 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.463 HG22 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.613 ' HA ' HG21 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.613 HG21 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.523 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.617 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -76.81 133.43 39.38 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 mm -58.0 -41.8 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.941 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 3.4 mmpt? . . . . . 0 C--O 1.233 0.191 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.422 HG21 ' CD1' ' A' ' 25' ' ' PHE . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CA ' ' HB3' ' A' ' 27' ' ' GLU . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.574 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 11' ' ' THR . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' CA ' ' A' ' 13' ' ' PHE . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HD23 ' A' ' 33' ' ' LEU . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 31' ' ' ILE . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.611 ' HA ' HG23 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.613 HG21 HG12 ' A' ' 54' ' ' VAL . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG12 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 HG12 ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.676 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.688 ' HA ' HG23 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HG3' HD13 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.501 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.632 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.632 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 HD13 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' HD13 ' A' ' 30' ' ' ILE . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' HD22 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 33' ' ' LEU . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.535 HG21 ' CD1' ' A' ' 25' ' ' PHE . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 12' ' ' LEU . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.461 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 33' ' ' LEU . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 9' ' ' CYS . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 61' ' ' VAL . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.671 0.272 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.638 ' HA ' HG23 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 33' ' ' LEU . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.449 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.561 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.624 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.607 ' HA ' HG23 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 22' ' ' GLU . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 51' ' ' LYS . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.451 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.592 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' ARG . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PHE . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.403 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.461 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.617 0.367 . . . . 0.0 111.387 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.2 ttp -115.35 48.88 1.12 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.86 179.87 39.12 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 119.915 -1.135 . . . . 0.0 113.418 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.14 -24.31 14.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 3.4 mmpt? -126.7 129.91 49.34 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.439 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.422 HG21 ' CD1' ' A' ' 25' ' ' PHE . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CA ' ' HB3' ' A' ' 27' ' ' GLU . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.574 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 11' ' ' THR . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' CA ' ' A' ' 13' ' ' PHE . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HD23 ' A' ' 33' ' ' LEU . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 31' ' ' ILE . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -81.07 134.42 35.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.98 -41.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.822 -179.613 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.9 -97.75 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.99 -0.528 . . . . 0.0 111.816 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 tpp -110.92 28.42 8.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.408 1.004 . . . . 0.0 111.579 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.89 166.72 36.03 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.049 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 7' ' ' GLU . . . -102.64 -115.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -44.06 103.54 0.03 OUTLIER 'General case' 0 C--N 1.347 0.482 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.611 ' HA ' HG23 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.613 HG21 HG12 ' A' ' 54' ' ' VAL . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG12 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 -72.69 134.96 45.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.27 -48.67 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.375 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.896 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -84.92 145.42 27.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.798 0.333 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 28.2 ttt 173.69 117.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.445 173.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -15.7 82.53 0.0 OUTLIER Glycine 0 C--N 1.345 1.077 0 N-CA-C 115.269 0.868 . . . . 0.0 115.269 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.13 6.96 12.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.025 0.912 . . . . 0.0 112.421 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 27.8 mtmm 74.62 49.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 HG12 ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.676 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.688 ' HA ' HG23 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.61 132.58 35.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.12 -43.7 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.99 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.881 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.869 ' HB2' ' HE2' ' A' ' 36' ' ' LYS . . . -87.2 146.8 25.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.614 0.245 . . . . 0.0 110.901 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 5' ' ' ALA . 6.3 ttt -171.01 120.23 0.52 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.83 79.47 0.0 OUTLIER Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' MET . . . -122.99 8.34 9.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.08 0.94 . . . . 0.0 112.747 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt 74.07 72.22 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HG3' HD13 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.501 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.632 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.632 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 HD13 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.869 ' HE2' ' HB2' ' A' ' 2' ' ' ALA . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.91 134.78 34.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -70.15 -59.03 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.373 -178.245 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.62 95.87 2.77 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -96.42 121.13 37.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 112.348 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -28.6 127.95 0.08 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.44 -1.254 . . . . 0.0 115.279 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.17 16.59 14.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.684 0.742 . . . . 0.0 111.484 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? 66.7 65.92 0.45 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' HD13 ' A' ' 30' ' ' ILE . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' HD22 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 33' ' ' LEU . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -87.46 133.73 33.71 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -54.89 -38.39 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.504 0.193 . . . . 0.0 111.251 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.757 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HB2' ' HE3' ' A' ' 36' ' ' LYS . . . -105.69 149.1 26.68 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.744 0.307 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -177.7 118.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 173.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -16.77 79.31 0.0 OUTLIER Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -121.84 7.13 9.88 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.249 1.025 . . . . 0.0 112.603 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 5.3 mtmm 75.42 50.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.535 HG21 ' CD1' ' A' ' 25' ' ' PHE . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HE3' ' HB2' ' A' ' 2' ' ' ALA . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 12' ' ' LEU . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.91 130.03 36.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.2 -39.85 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.859 -179.376 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.04 -86.35 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tpt -117.1 32.2 6.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.044 0.838 . . . . 0.0 112.844 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.08 164.8 32.35 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.173 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.22 -28.36 12.33 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -125.66 105.34 8.93 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.461 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 33' ' ' LEU . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 9' ' ' CYS . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 61' ' ' VAL . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 -79.72 141.35 36.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.37 -48.45 85.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.983 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.23 146.64 53.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.71 0.291 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' GLY . 3.2 mtt 170.48 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.42 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -4.25 68.58 0.0 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -111.41 0.52 16.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.533 1.167 . . . . 0.0 111.685 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 25.6 mtmm 78.62 49.54 0.04 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.187 0.304 . . . . 0.0 110.612 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.638 ' HA ' HG23 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' C ' HD23 ' A' ' 33' ' ' LEU . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.449 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.561 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.624 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -78.12 141.46 38.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.9 mm -63.89 -49.12 83.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.75 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.706 -0.158 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.73 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.721 0.408 . . . . 0.0 111.395 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.1 mtp -114.78 109.73 18.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.198 0.454 . . . . 0.0 111.599 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.61 -179.66 25.53 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.832 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.97 -32.94 11.04 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.19 124.99 43.67 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.249 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.607 ' HA ' HG23 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 22' ' ' GLU . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 51' ' ' LYS . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.451 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.592 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' ARG . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -83.07 133.84 35.05 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.56 -43.47 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.629 0.252 . . . . 0.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.763 -179.316 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . . . -72.59 155.56 39.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.07 0.462 . . . . 0.0 111.825 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 15.4 tpt 172.36 116.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.011 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.65 86.68 0.0 OUTLIER Glycine 0 C--N 1.347 1.18 0 CA-C-O 119.103 -0.832 . . . . 0.0 114.773 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.23 12.39 13.46 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.798 1.299 . . . . 0.0 112.828 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 35.1 mtmm 70.11 59.92 0.25 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PHE . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 2' ' ' ALA . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.403 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.461 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -76.81 133.43 39.38 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 mm -58.0 -41.8 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.941 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 3.4 mmpt? . . . . . 0 C--O 1.233 0.191 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.422 HG21 ' CD1' ' A' ' 25' ' ' PHE . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CA ' ' HB3' ' A' ' 27' ' ' GLU . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.574 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 11' ' ' THR . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' CA ' ' A' ' 13' ' ' PHE . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HD23 ' A' ' 33' ' ' LEU . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 31' ' ' ILE . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.611 ' HA ' HG23 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.613 HG21 HG12 ' A' ' 54' ' ' VAL . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG12 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 HG12 ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.676 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.688 ' HA ' HG23 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HG3' HD13 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.501 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.632 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.632 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 HD13 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' HD13 ' A' ' 30' ' ' ILE . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' HD22 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.535 HG21 ' CD1' ' A' ' 25' ' ' PHE . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 12' ' ' LEU . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.461 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 9' ' ' CYS . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 61' ' ' VAL . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.671 0.272 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.638 ' HA ' HG23 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.449 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.561 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.624 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.607 ' HA ' HG23 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 22' ' ' GLU . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 51' ' ' LYS . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.451 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.592 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' ARG . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PHE . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.403 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.461 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.617 0.367 . . . . 0.0 111.387 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.2 ttp -115.35 48.88 1.12 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.86 179.87 39.12 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 119.915 -1.135 . . . . 0.0 113.418 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.14 -24.31 14.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 3.4 mmpt? -126.7 129.91 49.34 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.439 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 34.2 mm-40 -124.87 127.08 46.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 6' ' ' LYS . 39.3 m-85 -126.38 134.51 51.03 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 14.3 p -129.97 138.97 51.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -99.29 130.15 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.422 HG21 ' CD1' ' A' ' 25' ' ' PHE . 39.7 p -78.81 140.53 38.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.796 0.332 . . . . 0.0 111.162 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -7.7 9.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.653 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.412 ' CA ' ' HB3' ' A' ' 27' ' ' GLU . 26.0 m-85 -147.58 152.14 41.01 Favored Pre-proline 0 C--O 1.234 0.261 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.82 134.79 12.24 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.103 1.869 . . . . 0.0 111.511 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -128.51 126.46 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.401 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.574 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.6 m -108.61 122.08 46.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.137 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.59 127.25 22.87 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.4 p -81.28 -34.13 32.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.108 0.48 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -105.05 156.51 17.99 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.174 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.09 -24.99 67.45 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -88.03 -14.41 39.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.45 0.167 . . . . 0.0 110.967 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.25 146.62 38.87 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -85.71 151.53 23.79 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.4 m -130.13 142.19 50.61 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 11' ' ' THR . 33.8 p90 -167.67 168.03 12.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -110.58 171.17 7.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' CA ' ' A' ' 13' ' ' PHE . 1.5 pm0 -75.79 126.33 30.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 111.237 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.2 63.6 0.77 Allowed Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.866 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -160.42 131.72 5.76 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.829 0.452 . . . . 0.0 109.916 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -83.53 122.75 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.195 0.522 . . . . 0.0 111.145 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 mm -110.12 143.87 19.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.491 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.58 125.29 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.069 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.3 tt -90.14 121.21 31.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.008 0.433 . . . . 0.0 110.477 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HD23 ' A' ' 33' ' ' LEU . 44.9 mm -93.33 -47.96 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.011 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -148.55 120.82 8.38 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -75.62 -19.27 59.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.634 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.43 106.76 13.55 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.6 p -109.22 7.04 25.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.53 0.75 46.67 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.042 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.54 136.49 39.37 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.1 134.73 47.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.026 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.18 -4.85 74.68 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.956 -0.64 . . . . 0.0 114.404 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -97.65 133.47 42.14 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.319 1.06 . . . . 0.0 111.258 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -120.03 147.69 44.5 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.816 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -114.46 129.48 56.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.045 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.23 173.7 23.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.361 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 132.97 54.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.404 0.621 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 31' ' ' ILE . 9.9 tt -144.65 113.99 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.888 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 63.71 47.94 3.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.996 0.427 . . . . 0.0 110.526 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 9.66 50.23 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -115.01 137.5 51.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.712 1.256 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -108.43 143.63 37.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.08 165.95 39.1 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.868 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 33.1 m -98.99 163.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.704 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 43.5 p90 170.82 140.98 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.08 113.93 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.305 2.67 . . . . 0.0 110.676 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.59 12.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.49 -1.687 . . . . 0.0 115.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -81.19 -10.04 59.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.173 0.897 . . . . 0.0 112.61 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -91.64 7.78 39.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.665 0.211 . . . . 0.0 111.173 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.49 156.75 43.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.4 p -117.54 128.13 74.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -81.07 134.42 35.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.161 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.98 -41.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.822 -179.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.9 -97.75 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.99 -0.528 . . . . 0.0 111.816 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 tpp -110.92 28.42 8.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.408 1.004 . . . . 0.0 111.579 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.89 166.72 36.03 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.049 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 7' ' ' GLU . . . -102.64 -115.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -44.06 103.54 0.03 OUTLIER 'General case' 0 C--N 1.347 0.482 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 45.2 mt-10 -142.14 128.95 20.53 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.409 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -122.32 161.77 22.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.411 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.7 m -137.38 145.96 43.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' HD13 ' A' ' 30' ' ' ILE . 23.8 ttp180 -102.41 131.01 49.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 37.5 p -72.28 115.27 11.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.328 . . . . 0.0 111.833 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 61' ' ' VAL . 72.0 mt -77.58 -20.08 54.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 94.0 m-85 -152.75 163.34 23.82 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 13' ' ' PHE . 97.2 Cg_endo -80.66 150.1 18.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.279 1.986 . . . . 0.0 112.453 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 75.1 t80 -143.22 129.07 19.45 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.782 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.611 ' HA ' HG23 ' A' ' 24' ' ' THR . 45.9 m -109.59 131.94 54.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.2 134.91 14.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.178 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -92.28 -28.18 17.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.455 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -122.57 163.22 20.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.48 -16.15 63.9 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -90.31 1.67 56.3 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.316 0.103 . . . . 0.0 111.051 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.07 145.58 35.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -86.95 157.28 19.52 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.573 0.225 . . . . 0.0 111.028 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 16' ' ' THR . 74.5 m -130.07 140.55 50.82 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 25.1 p90 -167.54 167.64 13.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.815 0.341 . . . . 0.0 111.69 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -109.05 165.21 11.76 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 4.8 tm-20 -67.1 129.52 40.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.849 0.356 . . . . 0.0 111.159 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.89 65.22 1.04 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -161.49 128.42 3.96 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' ARG . 48.7 mm -83.05 123.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.154 0.502 . . . . 0.0 111.774 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -107.68 142.34 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.674 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -82.29 124.68 30.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.6 tt -86.34 111.45 20.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 110.641 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.17 -48.57 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.746 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 t -151.22 127.29 10.45 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.1 mttt -80.97 -14.76 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.121 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.0 105.5 11.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.681 0.277 . . . . 0.0 110.336 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.613 HG21 HG12 ' A' ' 54' ' ' VAL . 29.6 p -104.38 3.39 32.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 -1.01 34.6 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.545 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 2.2 mt-10 -132.28 134.94 45.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.44 136.52 56.57 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 14.77 81.25 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.524 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 69.1 m95 -113.89 134.13 55.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.686 0.743 . . . . 0.0 111.082 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 57' ' ' ASP . 11.9 m0 -119.86 153.69 35.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.48 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 89.0 tttt -121.7 133.7 54.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.16 171.18 25.11 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.297 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.09 132.65 55.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.142 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.0 tp -154.59 122.32 5.82 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.254 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 66.24 39.45 4.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.269 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 4.4 71.16 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 119.244 -0.753 . . . . 0.0 114.961 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.47 144.81 47.79 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.591 1.196 . . . . 0.0 111.986 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -109.67 149.54 29.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -171.36 164.73 37.69 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.286 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG12 HG21 ' A' ' 38' ' ' THR . 18.0 m -97.16 159.47 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.731 0.301 . . . . 0.0 110.691 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 33.2 p90 174.42 140.7 0.18 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -51.67 114.42 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.092 2.528 . . . . 0.0 110.437 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.4 p30 -63.44 10.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.862 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.88 -4.44 54.84 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.294 0.952 . . . . 0.0 112.432 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' THR . 30.8 m-85 -100.32 8.72 43.51 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.431 -0.168 . . . . 0.0 110.861 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -152.79 130.05 11.25 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 122.345 0.258 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -96.76 138.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 15.7 tp60 -72.69 134.96 45.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.571 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.27 -48.67 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.375 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.896 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -84.92 145.42 27.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.798 0.333 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 28.2 ttt 173.69 117.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.445 173.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -15.7 82.53 0.0 OUTLIER Glycine 0 C--N 1.345 1.077 0 N-CA-C 115.269 0.868 . . . . 0.0 115.269 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.13 6.96 12.07 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.025 0.912 . . . . 0.0 112.421 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 27.8 mtmm 74.62 49.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.565 0.698 . . . . 0.0 109.719 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.36 133.08 34.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.939 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -123.7 157.29 34.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.69 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.19 145.26 39.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.813 0.34 . . . . 0.0 111.891 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -103.23 134.42 46.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.265 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.0 p -77.89 144.32 37.01 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 HG12 ' A' ' 61' ' ' VAL . 14.0 mt -104.92 -16.6 14.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.456 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.676 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 83.0 m-85 -158.99 156.33 26.34 Favored Pre-proline 0 C--N 1.343 0.294 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.1 130.99 19.86 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.048 1.832 . . . . 0.0 112.278 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -123.24 134.7 54.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.607 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.688 ' HA ' HG23 ' A' ' 24' ' ' THR . 44.7 m -109.56 134.26 52.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 111.044 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.74 133.75 12.38 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.916 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.5 m -88.09 -32.08 18.9 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.9 166.53 17.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 25.3 tt0 -64.49 -14.13 55.56 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.045 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -88.37 -23.17 23.45 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.23 140.77 29.48 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.25 164.28 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' HA ' ' A' ' 16' ' ' THR . 60.1 m -131.45 144.63 51.32 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' A' ' 48' ' ' LEU . 7.0 p90 -172.76 169.26 4.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.792 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' PHE . 16.4 tt0 -65.26 139.82 58.66 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.217 -0.302 . . . . 0.0 111.701 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 80.81 77.17 1.0 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.497 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.1 mm-40 -168.98 123.84 0.87 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.32 125.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.781 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.8 mt -109.35 149.39 12.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.682 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.73 123.68 32.15 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.8 tt -83.16 110.48 18.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.15 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG12 ' HA2' ' A' ' 46' ' ' GLY . 34.4 mm -91.92 -47.75 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.086 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -151.83 125.73 9.1 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -80.66 -18.46 47.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.673 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -115.65 88.29 2.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -101.82 4.54 40.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.53 -0.36 29.27 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.732 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 43' ' ' TRP . 5.7 tp10 -134.52 127.87 32.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 136.21 56.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.82 83.66 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.895 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 22.3 m95 -116.46 139.14 50.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.198 0.499 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -122.12 153.12 39.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.224 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -114.79 128.91 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.544 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.0 177.81 21.68 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.241 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.03 134.58 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 110.528 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 25' ' ' PHE . 40.0 tp -152.85 124.08 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.5 35.74 17.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.118 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.57 0.81 81.01 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.85 132.06 53.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.403 1.101 . . . . 0.0 111.069 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.4 142.27 36.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.5 47.39 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 119.969 -1.11 . . . . 0.0 114.074 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 14.0 m -97.42 165.06 2.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.652 0.263 . . . . 0.0 110.702 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 50.6 p90 173.78 136.01 0.13 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 43' ' ' TRP . 3.9 Cg_endo -50.17 152.07 8.43 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.882 2.388 . . . . 0.0 109.85 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.73 19.11 19.82 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.65 -11.4 53.91 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.381 0.991 . . . . 0.0 111.827 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 13' ' ' PHE . 82.8 m-85 -98.65 9.64 42.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.248 -0.181 . . . . 0.0 110.901 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 151.69 33.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.619 0.247 . . . . 0.0 110.701 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 12' ' ' LEU . 11.5 p -120.51 135.97 59.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.61 132.58 35.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.036 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.12 -43.7 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.99 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.881 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.869 ' HB2' ' HE2' ' A' ' 36' ' ' LYS . . . -87.2 146.8 25.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.614 0.245 . . . . 0.0 110.901 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 5' ' ' ALA . 6.3 ttt -171.01 120.23 0.52 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.83 79.47 0.0 OUTLIER Glycine 0 C--N 1.347 1.173 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' MET . . . -122.99 8.34 9.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.08 0.94 . . . . 0.0 112.747 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mttt 74.07 72.22 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -110.28 135.3 51.24 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.4 162.82 20.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.497 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.21 147.23 47.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 111.814 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HG3' HD13 ' A' ' 30' ' ' ILE . 29.0 ttt180 -107.62 136.85 46.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.763 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 58.5 p -79.9 135.81 36.51 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.501 ' C ' ' HG2' ' A' ' 27' ' ' GLU . 53.4 mt -103.55 -16.86 15.41 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.427 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -150.22 162.68 27.02 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 117.568 0.167 . . . . 0.0 110.835 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.06 137.9 12.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.587 2.192 . . . . 0.0 112.142 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -133.28 129.75 38.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.387 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.632 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.5 m -107.94 125.64 51.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.97 132.18 16.66 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -91.37 -30.49 16.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.164 0.507 . . . . 0.0 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -111.35 160.69 16.81 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.557 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.14 -21.06 65.84 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.91 9.1 31.86 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.16 141.02 34.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.618 0.247 . . . . 0.0 110.579 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 101.89 14.25 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.632 HG23 ' HA ' ' A' ' 16' ' ' THR . 56.9 m -77.45 144.94 37.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.14 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -168.99 162.3 11.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.44 168.27 9.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.501 ' HG2' ' C ' ' A' ' 12' ' ' LEU . 5.5 tm-20 -65.2 131.55 46.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.292 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 89.44 71.53 1.26 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.184 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 31.0 mt-10 -163.06 124.14 2.42 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 HD13 ' HG3' ' A' ' 10' ' ' ARG . 49.1 mm -79.37 123.84 36.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.251 0.548 . . . . 0.0 111.712 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.74 149.33 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.659 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -87.51 121.99 30.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 36' ' ' LYS . 4.9 tt -81.4 108.45 15.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.837 0.351 . . . . 0.0 110.236 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.6 mm -92.18 -47.88 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.926 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -152.42 126.18 8.95 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.869 ' HE2' ' HB2' ' A' ' 2' ' ' ALA . 21.2 mtmm -81.71 -15.83 53.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.559 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.44 87.94 2.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 71.4 p -91.61 4.52 52.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.5 -4.79 32.98 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -136.24 134.09 37.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 134.79 56.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.91 5.8 86.92 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.142 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -107.96 135.19 49.75 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.933 0.867 . . . . 0.0 110.786 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 46.0 m0 -121.09 156.47 32.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.574 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 65.7 tttm -120.31 128.9 53.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.79 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.31 179.88 20.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -125.78 133.57 52.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.994 0.426 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -157.28 127.06 6.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.96 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 63.51 38.27 9.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 6.35 55.35 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.099 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -111.43 132.79 54.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.922 0.861 . . . . 0.0 111.69 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.81 140.85 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.344 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.41 176.06 47.78 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.224 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 27.8 m -99.2 164.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.646 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 53.9 p90 174.73 136.8 0.16 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -48.8 150.58 6.25 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.895 2.397 . . . . 0.0 109.716 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.55 19.42 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -77.74 -9.41 58.99 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.424 1.011 . . . . 0.0 111.601 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -105.19 6.92 33.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.488 -0.085 . . . . 0.0 111.146 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -149.65 148.43 29.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.736 0.303 . . . . 0.0 111.054 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.0 139.39 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.631 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.91 134.78 34.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.172 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -70.15 -59.03 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.73 0.3 . . . . 0.0 111.14 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.373 -178.245 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.62 95.87 2.77 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -96.42 121.13 37.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.236 0.541 . . . . 0.0 112.348 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -28.6 127.95 0.08 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.44 -1.254 . . . . 0.0 115.279 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.17 16.59 14.92 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.684 0.742 . . . . 0.0 111.484 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? 66.7 65.92 0.45 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 3.8 mt-10 -110.32 135.09 51.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.881 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -122.73 162.27 22.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.109 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.02 145.15 31.37 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.026 -0.669 . . . . 0.0 112.394 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' HD13 ' A' ' 30' ' ' ILE . 52.1 ttm-85 -100.24 128.87 46.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.352 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.8 p -76.26 119.3 19.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 111.748 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 61' ' ' VAL . 63.2 mt -93.17 -14.26 27.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.893 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 93.4 m-85 -148.03 157.78 42.77 Favored Pre-proline 0 C--N 1.344 0.348 0 C-N-CA 122.258 0.223 . . . . 0.0 110.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 3.1 Cg_endo -85.25 152.17 10.73 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.037 2.491 . . . . 0.0 112.41 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 63.1 t80 -144.89 130.12 18.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.16 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 24' ' ' THR . 32.5 m -110.07 132.45 54.15 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.2 154.75 23.84 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.341 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -114.11 8.04 16.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -142.87 162.65 34.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.2 -14.43 62.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.738 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.36 -36.06 11.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.863 0.363 . . . . 0.0 110.701 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -68.1 142.94 55.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.732 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.35 149.79 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.9 m -129.31 127.26 40.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.5 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' HD22 ' A' ' 48' ' ' LEU . 47.2 p90 -154.02 163.35 40.23 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.764 0.316 . . . . 0.0 111.513 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' PRO . 9.5 mpt_? -109.86 165.48 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 140.6 58.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.673 0.273 . . . . 0.0 111.007 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.25 80.63 0.94 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.62 128.2 0.14 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.25 126.55 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.073 0.463 . . . . 0.0 111.238 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mt -111.16 154.55 12.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.047 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -92.2 121.18 33.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.5 tt -82.31 115.11 21.22 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 46' ' ' GLY . 41.2 mm -91.1 -48.69 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.387 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -154.87 133.99 12.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.309 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -84.59 -14.16 49.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.363 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.36 87.31 2.66 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 45' ' ' LYS . 73.0 p -88.78 4.08 48.79 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.23 -15.41 22.93 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.557 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mp0 -129.25 125.01 35.9 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.4 138.4 33.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.834 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.67 12.92 83.46 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.707 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 59.0 m95 -117.75 135.3 54.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.523 0.662 . . . . 0.0 110.289 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 39.1 m0 -120.78 163.55 17.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.99 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 21.3 mttt -124.65 127.27 47.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -143.69 -179.51 20.32 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.415 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 128.36 52.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 25' ' ' PHE . 8.3 tp -134.52 110.84 9.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.589 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.3 m120 50.56 39.66 21.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.863 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.11 73.89 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.2 mptp? -102.63 128.01 49.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.16 1.48 . . . . 0.0 111.45 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -106.6 140.43 39.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.89 -178.95 47.29 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.159 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG12 ' HG3' ' A' ' 45' ' ' LYS . 34.8 m -88.36 145.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 53.4 p90 -138.75 151.43 68.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 121.737 0.78 . . . . 0.0 112.941 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -29.8 -47.65 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 126.555 4.837 . . . . 0.0 117.838 -177.351 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 56' ' ' PRO . 17.7 t70 91.97 -38.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.716 1.206 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -77.3 -4.7 46.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HD2' ' HG2' ' A' ' 56' ' ' PRO . 23.6 m-85 -100.35 9.1 43.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.54 150.96 37.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 111.308 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' A' ' 12' ' ' LEU . 11.9 p -114.35 129.88 69.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.522 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -87.46 133.73 33.71 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.573 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -54.89 -38.39 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.504 0.193 . . . . 0.0 111.251 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.757 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HB2' ' HE3' ' A' ' 36' ' ' LYS . . . -105.69 149.1 26.68 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.744 0.307 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -177.7 118.63 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 173.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -16.77 79.31 0.0 OUTLIER Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -121.84 7.13 9.88 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.249 1.025 . . . . 0.0 112.603 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 5.3 mtmm 75.42 50.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.573 0.701 . . . . 0.0 109.503 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 42.0 mt-10 -73.72 133.67 43.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.99 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -125.81 156.69 39.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.747 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.27 145.5 32.8 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' HD13 ' A' ' 30' ' ' ILE . 48.9 ttp180 -103.5 130.39 50.87 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.535 HG21 ' CD1' ' A' ' 25' ' ' PHE . 40.7 p -76.38 123.28 25.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' C ' ' HG3' ' A' ' 27' ' ' GLU . 83.2 mt -84.14 -16.04 45.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.366 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 58.1 m-85 -157.61 155.59 27.34 Favored Pre-proline 0 C--N 1.343 0.308 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.46 135.41 20.14 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.288 1.992 . . . . 0.0 112.828 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -125.12 128.59 48.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.007 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 24' ' ' THR . 54.8 m -108.01 132.85 53.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.825 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.66 147.16 21.1 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.409 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -102.52 -9.62 20.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -143.5 159.02 43.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.904 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -53.37 -61.42 2.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.196 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -37.38 -48.66 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.6 139.76 56.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.645 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.82 151.79 25.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.714 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 16' ' ' THR . 76.3 m -130.27 142.52 50.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.857 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 16.9 p90 -169.98 167.73 8.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.863 0.363 . . . . 0.0 111.895 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.1 mpt_? -109.96 172.54 6.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 12' ' ' LEU . 32.3 tt0 -74.92 145.47 42.61 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.835 0.35 . . . . 0.0 111.779 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.18 5.18 73.33 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.201 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.24 129.54 52.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.961 0.38 . . . . 0.0 111.317 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 10' ' ' ARG . 49.1 mm -84.17 125.09 40.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.69 145.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.907 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -84.21 121.84 28.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 2.1 tt -83.28 111.09 18.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.085 0.469 . . . . 0.0 110.146 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 46' ' ' GLY . 26.4 mm -90.62 -49.12 13.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.757 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 25.1 t -148.71 115.24 5.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HE3' ' HB2' ' A' ' 2' ' ' ALA . 34.2 mtmt -76.95 -17.73 58.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -114.64 96.32 5.68 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 24.0 p -103.75 1.84 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.71 2.27 40.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.538 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -137.02 134.05 36.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 136.13 47.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.45 -3.74 80.78 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.506 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -107.2 135.84 48.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.508 0.654 . . . . 0.0 110.947 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ2' ' HD2' ' A' ' 36' ' ' LYS . 36.0 m0 -121.07 156.23 32.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.48 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 28.5 ttpp -119.99 129.02 54.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.954 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -140.88 177.14 21.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.292 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.13 134.54 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.335 0.588 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 25' ' ' PHE . 41.5 tp -152.6 118.87 5.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.478 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 65.13 38.92 5.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.624 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.19 9.24 71.83 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -114.14 137.08 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.011 1.406 . . . . 0.0 111.626 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.65 142.4 37.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -173.11 169.55 42.7 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.996 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 34.5 m -93.92 162.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.674 -0.263 . . . . 0.0 110.415 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 54' ' ' VAL . 51.7 p90 174.75 131.79 0.13 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.97 115.47 2.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.83 2.354 . . . . 0.0 110.152 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 p-10 -64.51 15.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.6 -11.26 59.67 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.341 0.973 . . . . 0.0 112.332 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.59 9.24 43.0 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.025 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 11' ' ' THR . . . -151.08 130.29 12.73 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.121 0.168 . . . . 0.0 111.158 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 12' ' ' LEU . 12.8 p -101.09 142.24 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.91 130.03 36.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.2 -39.85 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.859 -179.376 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.04 -86.35 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tpt -117.1 32.2 6.3 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.044 0.838 . . . . 0.0 112.844 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.08 164.8 32.35 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.173 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.22 -28.36 12.33 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -125.66 105.34 8.93 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 43.0 mt-10 -131.71 128.71 39.53 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.351 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -129.69 158.4 39.47 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 26.2 p -135.33 143.68 46.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.052 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -100.32 131.07 46.46 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.461 HG21 ' CD1' ' A' ' 25' ' ' PHE . 55.5 p -73.94 114.65 12.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 111.517 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.0 mt -78.83 -17.27 55.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -156.38 159.13 31.63 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 76.8 Cg_endo -78.32 154.39 28.26 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.185 1.923 . . . . 0.0 112.925 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.91 130.52 18.95 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.461 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 24' ' ' THR . 43.6 m -111.08 125.41 53.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.721 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.74 154.38 35.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.526 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.0 p -108.74 -5.66 16.24 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -144.84 171.13 14.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.424 0.154 . . . . 0.0 110.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.66 -4.74 25.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -94.2 -36.22 12.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.79 139.89 37.07 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.02 157.59 20.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 16' ' ' THR . 85.4 m -128.74 136.85 51.13 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 11' ' ' THR . 41.5 p90 -163.42 168.39 20.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -110.24 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 24.0 tt0 -68.55 144.21 54.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.58 75.32 0.94 Allowed Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.45 129.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -91.36 127.41 43.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 111.799 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.57 146.44 14.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -82.15 125.24 30.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.977 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -89.2 112.81 23.93 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.7 mm -87.78 -48.92 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.826 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 132.61 11.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.5 -10.19 59.11 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.971 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.05 102.45 9.64 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 31.3 p -106.32 -2.88 21.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.93 -11.23 27.27 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -130.92 132.74 45.3 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 138.77 58.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.74 -15.6 41.25 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.631 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -96.0 135.69 37.42 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 117.259 0.53 . . . . 0.0 111.303 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.52 160.93 23.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.515 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 59.9 tttt -126.52 135.17 50.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.016 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -147.41 175.36 26.81 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 126.46 52.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.082 0.467 . . . . 0.0 109.801 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.6 tp -135.77 109.66 8.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.945 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 58.08 42.14 22.92 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 111.355 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.05 -0.52 87.23 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 134.19 52.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.09 1.445 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.17 143.53 34.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.704 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.88 174.4 46.8 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.159 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.91 157.3 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.486 0.66 . . . . 0.0 110.8 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -162.91 163.29 17.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.186 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 19.4 Cg_exo -61.42 138.22 74.93 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.244 1.963 . . . . 0.0 110.244 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.84 2.39 56.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -105.02 -5.06 21.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.586 0.754 . . . . 0.0 111.219 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 9.2 m-85 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 122.808 0.443 . . . . 0.0 111.306 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 9' ' ' CYS . . . -152.83 157.88 41.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.284 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 61' ' ' VAL . 9.2 p -114.2 117.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.299 0.571 . . . . 0.0 110.491 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 47.1 tp60 -79.72 141.35 36.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.022 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.37 -48.45 85.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.983 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.23 146.64 53.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.71 0.291 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' GLY . 3.2 mtt 170.48 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.42 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -4.25 68.58 0.0 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -111.41 0.52 16.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.533 1.167 . . . . 0.0 111.685 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 25.6 mtmm 78.62 49.54 0.04 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.187 0.304 . . . . 0.0 110.612 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.67 131.46 34.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -123.47 165.62 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.984 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.8 p -145.81 145.43 30.78 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 30' ' ' ILE . 53.0 ttt85 -101.75 131.83 47.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.4 p -74.14 110.67 8.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 111.626 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.4 mt -80.61 -16.85 53.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -148.62 151.69 36.37 Favored Pre-proline 0 C--N 1.341 0.239 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 27' ' ' GLU . 95.7 Cg_endo -80.07 150.41 20.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.316 2.011 . . . . 0.0 112.592 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 56.8 t80 -142.91 129.32 20.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.638 ' HA ' HG23 ' A' ' 24' ' ' THR . 56.0 m -108.71 127.09 53.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.88 138.7 23.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.158 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.8 p -93.12 -16.43 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.455 . . . . 0.0 110.86 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.35 154.79 37.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.312 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -53.81 -62.86 1.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.193 -0.203 . . . . 0.0 110.644 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -45.97 -36.34 5.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -63.73 145.78 55.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.772 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.12 148.01 27.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 16' ' ' THR . 89.3 m -129.29 135.32 48.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.322 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 19.5 p90 -162.13 166.87 25.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 112.003 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -108.3 167.07 10.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 29.5 tt0 -65.08 135.77 55.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.808 0.337 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.05 75.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.0 129.92 1.79 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 10' ' ' ARG . 46.2 mm -88.89 123.48 41.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 111.972 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -109.12 147.41 13.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.487 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.9 120.68 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.5 tt -82.0 109.63 16.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.197 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -91.55 -47.73 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.914 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -153.39 129.24 10.19 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -81.69 -16.42 51.32 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.994 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -116.72 87.84 2.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 45' ' ' LYS . 36.7 p -85.03 4.43 33.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.85 -21.98 11.98 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.923 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -123.62 134.76 53.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 137.96 53.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 111.544 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.04 -10.69 46.59 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.126 -0.559 . . . . 0.0 114.438 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.449 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 63.5 m95 -94.29 136.79 34.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.74 0.77 . . . . 0.0 111.79 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 24.0 m0 -121.36 157.63 30.03 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 38' ' ' THR . 26.4 ttmt -122.52 131.97 54.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.28 173.43 23.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.344 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.44 134.37 55.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.283 0.563 . . . . 0.0 111.213 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.2 tp -158.19 123.7 4.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.435 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 66.86 41.67 2.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.58 43.01 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.278 -0.734 . . . . 0.0 114.805 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.89 139.81 50.6 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.46 1.13 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.11 142.66 36.43 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.74 169.82 42.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.74 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 34.7 m -96.85 159.6 3.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.655 0.74 . . . . 0.0 110.691 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.9 p90 -173.53 173.54 1.26 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.844 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.561 ' HB2' ' HD1' ' A' ' 59' ' ' PHE . 5.5 Cg_exo -71.11 140.47 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.314 . . . . 0.0 111.535 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.624 ' HB2' ' CD2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.74 0.59 57.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.927 -178.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -92.58 -3.59 54.77 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.486 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HD1' ' HB2' ' A' ' 56' ' ' PRO . 20.5 m-85 -102.4 5.72 39.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.75 127.08 10.65 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.512 0.196 . . . . 0.0 110.727 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.71 123.68 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.162 0.506 . . . . 0.0 111.748 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -78.12 141.46 38.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.324 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.9 mm -63.89 -49.12 83.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.75 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.706 -0.158 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.73 -78.76 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.721 0.408 . . . . 0.0 111.395 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.1 mtp -114.78 109.73 18.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.198 0.454 . . . . 0.0 111.599 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.61 -179.66 25.53 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.832 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.97 -32.94 11.04 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.19 124.99 43.67 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.249 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -135.09 128.02 31.42 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.214 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.05 156.32 40.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.614 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.8 m -136.04 145.69 46.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 37.9 ttt85 -101.39 133.21 46.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.21 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 40.6 p -76.9 120.87 22.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.901 0.382 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.21 -17.82 38.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.488 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -154.78 158.48 32.19 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-O 120.481 0.181 . . . . 0.0 110.74 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.12 149.17 64.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.398 2.065 . . . . 0.0 111.604 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HE2' ' HG2' ' A' ' 22' ' ' GLU . 47.0 t80 -142.79 128.77 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.296 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.607 ' HA ' HG23 ' A' ' 24' ' ' THR . 55.5 m -107.66 129.49 55.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.914 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 22' ' ' GLU . . . -76.15 130.42 10.86 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.988 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 p -85.85 -27.78 24.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.287 0.565 . . . . 0.0 110.86 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 22' ' ' GLU . 8.0 p-10 -124.1 160.27 28.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.287 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.1 -13.23 15.74 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.54 -18.92 21.72 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HE2' ' A' ' 15' ' ' TYR . 4.6 tt0 -81.58 88.13 6.22 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.04 0.448 . . . . 0.0 110.828 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 51' ' ' LYS . 7.9 tp -40.15 106.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.833 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.0 m -77.86 148.24 34.74 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.197 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 30.5 p90 -171.19 170.26 6.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.784 0.326 . . . . 0.0 111.775 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -110.41 171.13 7.64 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -71.89 144.29 49.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.681 0.277 . . . . 0.0 110.366 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 65.85 1.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -159.32 126.93 4.85 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.24 124.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.239 0.542 . . . . 0.0 111.387 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 48' ' ' LEU . 53.3 mt -106.35 138.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.451 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 1.9 m170 -75.66 121.79 23.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.084 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 36' ' ' LYS . 2.8 tt -82.48 104.35 12.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 46' ' ' GLY . 36.3 mm -83.09 -51.68 14.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.2 m -150.62 122.62 8.21 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE2' ' CZ2' ' A' ' 44' ' ' TRP . 77.6 mttt -79.06 -12.45 60.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.637 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.63 99.94 7.29 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 28.9 p -108.45 0.06 20.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.21 0.24 35.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.437 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -134.08 125.6 28.37 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.96 141.5 58.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.751 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.78 15.79 78.02 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.128 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 67.5 m95 -118.98 136.58 54.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.402 0.601 . . . . 0.0 111.191 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CZ2' ' HE2' ' A' ' 36' ' ' LYS . 35.7 m0 -120.91 157.81 29.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 33.0 tttt -126.72 134.69 50.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -148.48 -179.85 24.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.181 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.27 134.62 53.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 31' ' ' ILE . 11.7 tp -143.28 113.71 7.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.855 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.95 43.91 17.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 111.289 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.13 -0.69 78.47 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 115.148 0.819 . . . . 0.0 115.148 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . 13.5 mptt -110.68 135.16 51.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.805 1.303 . . . . 0.0 110.95 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.0 143.67 33.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.58 168.82 41.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.63 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 163.8 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.752 0.787 . . . . 0.0 110.442 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.592 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 27.7 p90 -171.99 173.58 1.58 Allowed Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.95 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 55' ' ' PHE . 2.7 Cg_exo -68.24 140.13 48.04 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.981 2.454 . . . . 0.0 112.532 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.19 8.12 31.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.186 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -101.76 -11.07 19.39 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.434 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' THR . 29.8 m-85 -99.12 3.0 46.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.273 0.101 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' ARG . . . -147.58 126.17 12.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.608 0.242 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.26 138.11 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -83.07 133.84 35.05 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.56 -43.47 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.629 0.252 . . . . 0.0 111.035 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.763 -179.316 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . . . -72.59 155.56 39.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.07 0.462 . . . . 0.0 111.825 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 15.4 tpt 172.36 116.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.011 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' MET . . . -19.65 86.68 0.0 OUTLIER Glycine 0 C--N 1.347 1.18 0 CA-C-O 119.103 -0.832 . . . . 0.0 114.773 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 6' ' ' LYS . . . -118.23 12.39 13.46 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.798 1.299 . . . . 0.0 112.828 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 35.1 mtmm 70.11 59.92 0.25 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 44.1 mt-10 -97.67 134.62 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -124.61 158.12 33.83 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.013 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.4 p -155.8 146.7 22.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -105.31 134.34 48.59 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.795 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 25' ' ' PHE . 36.0 p -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.887 0.375 . . . . 0.0 111.971 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.9 mt -100.78 -20.95 15.32 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 90.6 m-85 -147.9 148.43 30.07 Favored Pre-proline 0 C--O 1.234 0.255 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PHE . 11.5 Cg_exo -70.18 134.93 28.23 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.113 1.875 . . . . 0.0 111.664 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 89.9 t80 -128.69 129.53 45.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.532 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.8 m -108.94 129.75 55.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.121 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.85 145.24 27.14 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.342 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -104.37 11.91 34.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.791 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.42 165.25 33.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.027 0.531 . . . . 0.0 110.511 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.15 -16.1 62.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -95.1 -34.22 12.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.63 141.99 58.21 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.249 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 48' ' ' LEU . 12.2 mt -82.99 151.82 25.69 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 112.067 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.66 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.1 m -129.83 131.77 46.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 11' ' ' THR . 11.8 p90 -158.54 167.0 30.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -112.92 167.44 10.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.031 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.69 137.83 58.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.758 0.314 . . . . 0.0 110.373 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.07 69.11 1.42 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.42 129.91 5.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.9 mm -90.35 120.76 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.181 0.515 . . . . 0.0 111.478 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.03 148.07 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.322 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -84.01 116.28 22.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -78.88 110.46 14.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.366 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 46' ' ' GLY . 40.9 mm -90.59 -47.13 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.633 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.7 m -152.98 120.61 6.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 2' ' ' ALA . 8.3 mtmp? -75.96 -20.83 57.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.753 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.44 91.39 3.63 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 45.1 p -90.82 5.86 46.69 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 -5.47 39.84 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.342 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -134.37 122.13 22.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.69 139.14 51.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.391 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.49 89.64 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.683 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.403 ' HE3' ' HB ' ' A' ' 54' ' ' VAL . 58.4 m95 -115.8 138.87 50.72 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 117.804 0.802 . . . . 0.0 111.281 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 27.5 m0 -121.87 162.51 20.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' CG2' ' A' ' 38' ' ' THR . 62.0 tttm -129.0 140.25 51.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . -152.17 -178.87 27.29 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.263 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 133.88 54.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.772 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 23' ' ' LEU . 49.9 tp -158.98 125.19 4.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.532 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 67.03 38.94 3.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.065 0.46 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.44 9.71 55.71 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -122.28 142.54 50.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.366 1.083 . . . . 0.0 111.333 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.83 142.37 36.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.29 174.16 44.31 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 119.743 -1.218 . . . . 0.0 113.481 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HB ' ' HE3' ' A' ' 43' ' ' TRP . 30.5 m -99.16 161.58 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.502 0.668 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.461 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 48.5 p90 -170.19 167.85 4.58 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.423 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . 9.2 Cg_exo -64.18 131.34 30.03 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.744 1.629 . . . . 0.0 110.122 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' CG ' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -87.64 -10.07 52.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.434 -176.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -90.31 0.75 57.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.825 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 6.0 m-85 -99.09 5.49 46.94 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.073 0.549 . . . . 0.0 110.86 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.75 156.84 42.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.366 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.3 p -119.6 127.58 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -76.81 133.43 39.38 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 mm -58.0 -41.8 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.941 -179.957 . . . . . . . . 0 0 . 1 stop_ save_